BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 37350960)

  • 1. Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study.
    Tao H; Yu Z; Dong Y; Liu L; Peng L; Chen X
    Front Immunol; 2023; 14():1160312. PubMed ID: 37350960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study.
    Xiao W; Li Y; Zhuang Z; Song Z; Wang W; Huang N; Dong X; Jia J; Liu Z; Zhao Y; Qi L; Huang T
    Lipids Health Dis; 2024 Jun; 23(1):163. PubMed ID: 38831433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
    Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the use of lipid-lowering drugs and the risk of inflammatory bowel disease.
    Liu X; Lv Z; Xie Z; Wang Q; Yao W; Yu J; Jing Q; Meng X; Ma B; Xue D; Hao C
    Eur J Clin Invest; 2023 Dec; 53(12):e14067. PubMed ID: 37515404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
    Liang Z; Zhao L; Lou Y; Liu S
    QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
    Tan Z; Hong J; Sun A; Ding M; Shen J
    Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
    Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
    EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
    Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
    PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
    Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
    EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian randomization study of lipid metabolism characteristics and migraine risk.
    Hong P; Han L; Wan Y
    Eur J Pain; 2024 Jul; 28(6):978-986. PubMed ID: 38183343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
    Harrison SC; Holmes MV; Burgess S; Asselbergs FW; Jones GT; Baas AF; van 't Hof FN; de Bakker PIW; Blankensteijn JD; Powell JT; Saratzis A; de Borst GJ; Swerdlow DI; van der Graaf Y; van Rij AM; Carey DJ; Elmore JR; Tromp G; Kuivaniemi H; Sayers RD; Samani NJ; Bown MJ; Humphries SE
    JAMA Cardiol; 2018 Jan; 3(1):26-33. PubMed ID: 29188294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease.
    Huang K; Huang S; Xiong M
    Lipids Health Dis; 2024 Jan; 23(1):31. PubMed ID: 38287401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
    Chi G; Pei J; Li X
    PLoS One; 2024; 19(6):e0305220. PubMed ID: 38848323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study.
    He JY; Zhang X; Wang K; Lv WQ
    J Nutr; 2022 May; 152(5):1283-1290. PubMed ID: 35349717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetically predicted lipid traits and lipid-modifying targets with heart failure.
    Xiao J; Ji J; Zhang N; Yang X; Chen K; Chen L; Huang W
    Eur J Prev Cardiol; 2023 Mar; 30(4):358-366. PubMed ID: 36520639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering drugs and inflammatory bowel disease's risk: a drug-target Mendelian randomization study.
    Zhao J; Chen R; Luo M; Gong H; Li K; Zhao Q
    Diabetol Metab Syndr; 2024 Jan; 16(1):12. PubMed ID: 38191425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study.
    Ma W; Chen H; Zhang Z; Xiong Y
    PLoS One; 2024; 19(2):e0293960. PubMed ID: 38416763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
    Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
    Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis.
    Lou C; Meng Z; Shi YY; Zheng R; Qian SZ; Pan J
    Front Cardiovasc Med; 2023; 10():1217922. PubMed ID: 37621565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.